Optimum non-invasive predictive indicators for metabolic dysfunction-associated fatty liver disease and its subgroups in the Chinese population: A retrospective case-control study

OBJECTIVE: Metabolic dysfunction-associated fatty liver disease (MAFLD) affects 25% of the population without approved drug therapy. According to the latest consensus, MAFLD is divided into three subgroups based on different diagnostic modalities, including Obesity, Lean, and Type 2 diabetes mellitu...

Descripción completa

Detalles Bibliográficos
Autores principales: Liu, Jing, Duan, Shaojie, Wang, Che, Wang, Yutong, Peng, Hongye, Niu, Zuohu, Yao, Shukun
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751395/
https://www.ncbi.nlm.nih.gov/pubmed/36531447
http://dx.doi.org/10.3389/fendo.2022.1035418

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9751395/
https://www.ncbi.nlm.nih.gov/pubmed/36531447
http://dx.doi.org/10.3389/fendo.2022.1035418

Ejemplares similares